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Abstract 
Peritoneal adhesions are pathological fibrous structures that connect together organ and 
membrane at sites where the peritoneum is damaged. Post-operative adhesions forming 
after abdominal surgery have a very high occurrence and can develop painful and morbid 
complications. Numerous strategies aiming at adhesion prevention were developed, but 
no clinical treatment resulted in a complete inhibition of adhesion formation. One of the 
most investigated targets is the deposition and persistence of fibrin at injury sites, which 
was shown to be an important triggering mechanism for the maturation of adhesion into 
permanent fibrous structures. The fibrinolytic system is strongly involved in persistence 
of fibrin in the peritoneum, and plasminogen activators are its main regulators. Tissue-
type plasminogen activator (tPA) is a clinically used fibrinolytic agent that showed some 
of the most efficient effects on adhesion prevention. 
The fibrin A and B knob sequences are peptides found at the N-terminus of the ? and ?
chains of fibrinogen. Upon exposure, knob sequences trigger the polymerization of fibrin 
monomers. A variant of the A-knob sequence, GPRP, was shown to inhibit fibrin 
polymerization efficiently, when present as a free peptide. 
The aim of this project is to design and produce a chimeric protein consisting of a 
domain-deleted variant of tPA with a GPRP knob sequence fused to its N-terminus. The 
hypothesis is that the addition of the knob sequence on tPA will result in an enhanced 
therapeutic potential for adhesion prevention, with a synergic effect on fibrin targeting 
and degradation. 
Cloning and expression of the chimeric protein in E.Coli resulted in the formation of 
insoluble inactive aggregates called inclusion bodies. A renaturation procedure was 
design to recover enzymatically active proteins from inclusion bodies. This process 
involved the solubilization of insoluble aggregates in high concentrations of a chaotrope, 
the refolding of proteins by dilution in an optimized renaturation buffer, and the 
purification of protein by a chromatographic technique. The resulting chimeric protein 
showed a high enzymatic activity, thus validating the production process. 
2
